During the past decade, Stanford University, Department of Psychiatry and Behavioral Sciences conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stanford University, Department of Psychiatry and Behavioral Sciences" #1 sponsor was "Stanford University" with 28 trials, followed by "Biohaven Pharmaceuticals, Inc." with 1 trials sponsored, "COMPASS Pathways" with 1 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford University, Department of Psychiatry and Behavioral Sciences" #1 collaborator was "National Institute of Mental Health (NIMH)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "American Diabetes Association" with 1 trials as a collaborator, "Brown University" with 1 trials as a collaborator and "Cornell University" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Stanford University, Department of Psychiatry and Behavioral Sciences" are "Treatment Resistant Depression" (6 trials), "Depression" (4 trials), "Anxiety" (3 trials), "Binge Eating" (2 trials) and "Eating Disorders" (2 trials). Many other conditions were trialed in "Stanford University, Department of Psychiatry and Behavioral Sciences" in a lesser frequency.

Most popular intervention types in "Stanford University, Department of Psychiatry and Behavioral Sciences" are "Behavioral" (13 trials), "Drug" (7 trials), "Device" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Active TBS-DLPFC" (5 trials), "Sham TBS-DLPFC" (4 trials), "Computerized Neurobehavioral Intervention" (3 trials), "Open label TBS-DLPFC" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Stanford University, Department of Psychiatry and Behavioral Sciences" are 27 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Stanford University, Department of Psychiatry and Behavioral Sciences". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Stanford University, Department of Psychiatry and Behavioral Sciences, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Stanford University, Department of Psychiatry and Behavioral Sciences, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 18 trials that are defined as “Not Applicable".